Connect with us

Finance

Armata Pharmaceuticals Announces Appointment of Life Sciences Accounting and Finance Veteran David House as SVP of Finance and Principal Financial Officer

Published

on

Armata Pharmaceuticals Announces Appointment of Life Sciences Accounting and Finance Veteran David House as SVP of Finance and Principal Financial Officer

LOS ANGELES, Aug. 15, 2024 /PRNewswire/ — Armata Pharmaceuticals, Inc. (NYSE American: ARMP) (“Armata” or the “Company“), a biotechnology company focused on the development of high-purity, pathogen-specific bacteriophage therapeutics for antibiotic-resistant and difficult-to-treat bacterial infections, today announced the appointment of life sciences accounting and finance veteran David House as Senior Vice President, Finance, effective August 16th. Armata’s Corporate Controller, Richard Rychlik, will retain the position of Controller.

“We are delighted to welcome David to the Armata team,” stated Dr. Deborah Birx, Chief Executive Officer of Armata. “David’s extensive experience and track record of serving in senior accounting and finance roles within both clinical and commercial stage life sciences companies will serve us well as we continue to advance our two distinct programs – AP-PA02 and AP-SA02 – and prepare to initiate pivotal studies next year. This is an exciting time at Armata, and the addition of David to our senior team helps ensure that we are best positioned to achieve long-term success as we work to introduce an exciting new class of anti-infectives to treat serious drug-resistant bacterial infections.”  

Before joining Armata, Mr. House served as Corporate Controller and Vice President of Accounting at ZO Skin Health, Inc., a multi-channel physician-dispensed skincare company, from October 2018 to May 2024. At ZO Skin Health, he led global accounting operations, managed financial reporting, and played a crucial role in the company’s acquisition by Blackstone. He also established international subsidiaries and oversaw financial integration for mergers and acquisitions. Mr. House’s experience includes similar financial leadership roles at Peregrine Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, and Avid Bioservices, Inc. (CDMO), a contract development and manufacturing organization where he served as Controller and was responsible for implementing ASC 606, managing technical accounting, and conducting Securities and Exchange Commission (the “SEC“) reporting.

Mr. House’s career also includes roles at Viant, Inc. (DSP), Sourcing Solutions, LLC, and Apria Healthcare (APR), where he held various accounting and financial management positions. In the early stages of his career, Mr. House worked as a Senior Auditor at Windes, a public accounting firm. There, he managed comprehensive audits for public, private, and not-for-profit entities and contributed to SEC filings and internal control evaluations. Mr. House holds a Bachelor of Arts in Business Administration with an Accounting concentration from California State University, Fullerton. He obtained his California Certified Public Accountant license, which is currently inactive.

About Armata Pharmaceuticals, Inc.

Advertisement

Armata is a clinical-stage biotechnology company focused on the development of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. Armata is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. Armata is committed to advancing phage therapy with drug development expertise that spans bench to clinic including in-house phage specific cGMP manufacturing.

Forward Looking Statements

This communication contains “forward-looking” statements as defined by the Private Securities Litigation Reform Act of 1995. These statements relate to future events, results or to Armata’s future financial performance and involve known and unknown risks, uncertainties and other factors which may cause Armata’s actual results, performance or events to be materially different from any future results, performance or events expressed or implied by the forward-looking statements. In some cases, you can identify these statements by terms such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “will,” “would” or the negative of those terms, and similar expressions. These forward-looking statements reflect management’s beliefs and views with respect to future events and are based on estimates and assumptions as of the date of this communication and are subject to risks and uncertainties including risks related to Armata’s development of bacteriophage-based therapies; ability to staff and maintain its production facilities under fully compliant current Good Manufacturing Practices; ability to meet anticipated milestones in the development and testing of the relevant product; ability to be a leader in the development of phage-based therapeutics; ability to achieve its vision, including improvements through engineering and success of clinical trials; ability to successfully complete preclinical and clinical development of, and obtain regulatory approval of its product candidates and commercialize any approved products on its expected timeframes or at all; and Armata’s estimates regarding anticipated operating losses, capital requirements and needs for additional funds. Additional risks and uncertainties relating to Armata and its business can be found under the caption “Risk Factors” and elsewhere in Armata’s filings and reports with the SEC, including in Armata’s Annual Report on Form 10-K, filed with the SEC on March 21, 2024, and in its subsequent filings with the SEC.

Armata expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in Armata’s expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based.

Media Contacts:

Advertisement

At Armata:
Pierre Kyme
Armata Pharmaceuticals, Inc.
[email protected]
310-665-2928 x234

Investor Relations:
Joyce Allaire
LifeSci Advisors, LLC
[email protected]
212-915-2569

SOURCE Armata Pharmaceuticals, Inc.

Finance

Africa’s climate finance rules are growing, but they’re weakly enforced – new research

Published

on

Africa’s climate finance rules are growing, but they’re weakly enforced – new research

Climate change is no longer just about melting ice or hotter summers. It is also a financial problem. Droughts, floods, storms and heatwaves damage crops, factories and infrastructure. At the same time, the global push to cut greenhouse gas emissions creates risks for countries that depend on oil, gas or coal.

These pressures can destabilise entire financial systems, especially in regions already facing economic fragility. Africa is a prime example.

Although the continent contributes less than 5% of global carbon emissions, it is among the most vulnerable. In Mozambique, repeated cyclones have destroyed homes, roads and farms, forcing banks and insurers to absorb heavy losses. Kenya has experienced severe droughts that hurt agriculture, reducing farmers’ ability to repay loans. In north Africa, heatwaves strain electricity grids and increase water scarcity.

These physical risks are compounded by “transition risks”, like declining revenues from fossil fuel exports or higher borrowing costs as investors worry about climate instability. Together, they make climate governance through financial policies both urgent and complex. Without these policies, financial systems risk being caught off guard by climate shocks and the transition away from fossil fuels.

This is where climate-related financial policies come in. They provide the tools for banks, insurers and regulators to manage risks, support investment in greener sectors and strengthen financial stability.

Advertisement

Regulators and banks across Africa have started to adopt climate-related financial policies. These range from rules that require banks to consider climate risks, to disclosure standards, green lending guidelines, and green bond frameworks. These tools are being tested in several countries. But their scope and enforcement vary widely across the continent.

My research compiles the first continent-wide database of climate-related financial policies in Africa and examines how differences in these policies – and in how binding they are – affect financial stability and the ability to mobilise private investment for green projects.

A new study I conducted reviewed more than two decades of policies (2000–2025) across African countries. It found stark differences.

South Africa has developed the most comprehensive framework, with policies across all categories. Kenya and Morocco are also active, particularly in disclosure and risk-management rules. In contrast, many countries in central and west Africa have introduced only a few voluntary measures.

Why does this matter? Voluntary rules can help raise awareness and encourage change, but on their own they often do not go far enough. Binding measures, on the other hand, tend to create stronger incentives and steadier progress. So far, however, most African climate-related financial policies remain voluntary. This leaves climate risk as something to consider rather than a firm requirement.

Advertisement

Uneven landscape

In Africa, the 2015 Paris Agreement marked a clear turning point. Around that time, policy activity increased noticeably, suggesting that international agreements and standards could help create momentum and visibility for climate action. The expansion of climate-related financial policies was also shaped by domestic priorities and by pressure from international investors and development partners.

But since the late 2010s, progress has slowed. Limited resources, overlapping institutional responsibilities and fragmented coordination have made it difficult to sustain the earlier pace of reform.

Looking across the continent, four broad patterns have emerged.

A few countries, such as South Africa, have developed comprehensive frameworks. These include:

  • disclosure rules (requirements for banks and companies to report how climate risks affect them)

  • stress tests (simulations of extreme climate or transition scenarios to see whether banks would remain resilient).

Others, including Kenya and Morocco, are steadily expanding their policy mix, even if institutional capacity is still developing.

Advertisement

Some, such as Nigeria and Egypt, are moderately active, with a focus on disclosure rules and green bonds. (Those are bonds whose proceeds are earmarked to finance environmentally friendly projects such as renewable energy, clean transport or climate-resilient infrastructure.)

Finally, many countries in central and west Africa have introduced only a limited number of measures, often voluntary in nature.

This uneven landscape has important consequences.

The net effect

In fossil fuel-dependent economies such as South Africa, Egypt and Algeria, the shift away from coal, oil and gas could generate significant transition risks. These include:

  • financial instability, for example when asset values in carbon-intensive sectors fall sharply or credit exposures deteriorate

  • stranded assets, where fossil fuel infrastructure and reserves lose their economic value before the end of their expected life because they can no longer be used or are no longer profitable under stricter climate policies.

Addressing these challenges may require policies that combine investment in new, low-carbon sectors with targeted support for affected workers, communities and households.

Advertisement

Climate finance affects people directly. When droughts lead to loan defaults, local banks are strained. Insurance companies facing repeated payouts after floods may raise premiums. Pension funds invested in fossil fuels risk devaluations as these assets lose value. Climate-related financial policies therefore matter not only for regulators and markets, but also for jobs, savings, and everyday livelihoods.

At the same time, there are opportunities.

Firstly, expanding access to green bonds and sustainability-linked loans can channel private finance into renewable energy, clean transport, or resilient infrastructure.

Secondly, stronger disclosure rules can improve transparency and investor confidence.

Thirdly, regional harmonisation through common reporting standards, for example, would reduce fragmentation. This would make it easier for Africa to attract global climate finance.

Advertisement

Looking ahead

International forums such as the UN climate conferences (COP) and the G20 have helped to push this agenda forward, mainly by setting expectations rather than hard rules. These initiatives create pressure and guidance. But they remain soft law. Turning them into binding, enforceable rules still depends on decisions taken by national regulators and governments.

International partners such as the African Development Bank and the African Union could support coordination by promoting continental standards that define what counts as a green investment. Donors and multilateral lenders may also provide technical expertise and financial support to countries with weaker systems, helping them move from voluntary guidelines toward more enforceable rules.

South Africa, already a regional leader, could share its experience with stress testing and green finance frameworks.

Africa also has the potential to position itself as a hub for renewable energy and sustainable finance. With vast solar and wind resources, expanding urban centres, and an increasingly digital financial sector, the continent could leapfrog towards a greener future if investment and regulation advance together.

Success stories in Kenya’s sustainable banking practices and Morocco’s renewable energy expansion show that progress is possible when financial systems adapt.

Advertisement

What happens next will matter greatly. By expanding and enforcing climate-related financial rules, Africa can reduce its vulnerability to climate shocks while unlocking opportunities in green finance and renewable energy.

Continue Reading

Finance

'There Could Be A Whole Other Life He's Living' 'The Ramsey Show' Host Says After Wife Finds $209K Debt Behind Her Back

Published

on

'There Could Be A Whole Other Life He's Living' 'The Ramsey Show' Host Says After Wife Finds 9K Debt Behind Her Back
A hidden financial discovery exposed the scale of debt inside a long-running marriage. Anne, a caller from Pittsburgh, reached out to “The Ramsey Show” for guidance after uncovering $209,000 in credit card balances. Married for 19 years and now in her 50s, she said the balances accumulated without her knowledge. She said her husband managed nearly all household finances. Anne added that her name was not on the primary bank account. She had no online access, and both personal and business expense
Continue Reading

Finance

Will Trump’s US$200 Billion MBS Purchase Directive Reshape Federal National Mortgage Association’s (FNMA) Core Narrative?

Published

on

Will Trump’s US0 Billion MBS Purchase Directive Reshape Federal National Mortgage Association’s (FNMA) Core Narrative?
In early January 2026, President Donald Trump directed government representatives, widely understood to include Fannie Mae and Freddie Mac, to purchase US$200 billion in mortgage-backed securities to push mortgage rates and monthly payments lower. Beyond its housing affordability goal, the move highlights how heavily the administration is leaning on government-sponsored enterprises like Fannie Mae to influence credit conditions and the mortgage market’s structure. With this large-scale…
Continue Reading
Advertisement

Trending